US 11,730,168 B2
Antimicrobial superabsorbent compositions
Thomas Hall, Birmingham (GB); Sophie Constance Cox, Birmingham (GB); Liam Michael Grover, Birmingham (GB); and David Kershaw, Abingdon (GB)
Assigned to Matoke Holdings Limited, Abingdon (GB)
Appl. No. 16/753,570
Filed by Matoke Holdings Limited, Abingdon (GB)
PCT Filed Oct. 16, 2018, PCT No. PCT/GB2018/052976
§ 371(c)(1), (2) Date Apr. 3, 2020,
PCT Pub. No. WO2019/077335, PCT Pub. Date Apr. 25, 2019.
Claims priority of application No. 1716986 (GB), filed on Oct. 16, 2017.
Prior Publication US 2020/0289701 A1, Sep. 17, 2020
Int. Cl. A61K 38/44 (2006.01); A61K 38/48 (2006.01); A61L 26/00 (2006.01); A01N 63/50 (2020.01); A01N 59/00 (2006.01); A61K 9/06 (2006.01); A61K 38/36 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/40 (2006.01)
CPC A01N 59/00 (2013.01) [A01N 63/50 (2020.01); A61K 9/06 (2013.01); A61K 38/363 (2013.01); A61K 38/443 (2013.01); A61K 38/4833 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/40 (2013.01); A61L 26/008 (2013.01); A61L 26/0014 (2013.01); A61L 26/0042 (2013.01); A61L 26/0047 (2013.01); A61L 26/0066 (2013.01); A61L 26/0095 (2013.01); C12Y 101/03004 (2013.01)] 17 Claims
 
1. A sterile composition comprising:
an enzyme that is able to convert a substrate to release hydrogen peroxide;
a substrate for the enzyme; and
a superabsorbent component,
wherein the composition is in the form of a powder, wherein the powder has a mean and/or modal particle diameter of 3000 μm or less, and wherein the composition does not contain any peroxidase.